Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 2.1.1.364 - [histone H3]-lysine4 N-methyltransferase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Breast Neoplasms
Identification of Cyproheptadine as an Inhibitor of SET Domain Containing Lysine Methyltransferase 7/9 (Set7/9) That Regulates Estrogen-Dependent Transcription.
SET7/9 inhibits oncogenic activities through regulation of Gli-1 expression in breast cancer.
SET7/9 promotes multiple malignant processes in breast cancer development via RUNX2 activation and is negatively regulated by TRIM21.
Carcinogenesis
Identification of Cyproheptadine as an Inhibitor of SET Domain Containing Lysine Methyltransferase 7/9 (Set7/9) That Regulates Estrogen-Dependent Transcription.
Opposite Effects of SET7/9 on Apoptosis of Human Acute Myeloid Leukemia Cells and Lung Cancer Cells.
Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progression.
Set7/9 controls proliferation and genotoxic drug resistance of NSCLC cells.
Carcinoma, Hepatocellular
SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.
Colorectal Neoplasms
Resveratrol induces p53 in colorectal cancer through SET7/9.
Diabetes Mellitus
Role of SET7/9 in the progression of ischemic renal injury in diabetic and non-diabetic rats.
Diabetes Mellitus, Type 1
Histone H2AK119 and H2BK120 Monoubiquitination Modulate SET7/9 and SUV39H1 in Type 1 Diabetes Induced Renal Fibrosis.
Diabetes Mellitus, Type 2
SET7/9 Enzyme Regulates Cytokine-induced Expression of Inducible Nitric-oxide Synthase through Methylation of Lysine 4 at Histone 3 in the Islet ? Cell.
Glioma
SET7/9 promotes H3K4me3 at lncRNA DRAIC promoter to modulate growth and metastasis of glioma.
Glomerulonephritis, IGA
Inhibition of SET Domain-Containing Lysine Methyltransferase 7/9 Ameliorates Renal Fibrosis.
Glomerulonephritis, Membranous
Inhibition of SET Domain-Containing Lysine Methyltransferase 7/9 Ameliorates Renal Fibrosis.
Infections
Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1.
Insulinoma
Methyltransferase Set7/9 maintains transcription and euchromatin structure at islet-enriched genes.
Leukemia
Histone H3K4 Methyltransferases as Targets for Drug-Resistant Cancers.
SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stress.
Substrate and product specificities of SET domain methyltransferases.
Leukemia, Myeloid, Acute
Opposite Effects of SET7/9 on Apoptosis of Human Acute Myeloid Leukemia Cells and Lung Cancer Cells.
Lung Neoplasms
Opposite Effects of SET7/9 on Apoptosis of Human Acute Myeloid Leukemia Cells and Lung Cancer Cells.
Set7/9 controls proliferation and genotoxic drug resistance of NSCLC cells.
Metabolic Diseases
Set7/9, a methyltransferase, regulates the thermogenic program during brown adipocyte differentiation through the modulation of p53 acetylation.
Neoplasm Metastasis
SET7/9 promotes H3K4me3 at lncRNA DRAIC promoter to modulate growth and metastasis of glioma.
Neoplasms
KMT Set7/9 affects genotoxic stress response via the Mdm2 axis.
KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress.
Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo.
Methylation of SUV39H1 by SET7/9 results in heterochromatin relaxation and genome instability.
Methylation-acetylation interplay activates p53 in response to DNA damage.
Opposite Effects of SET7/9 on Apoptosis of Human Acute Myeloid Leukemia Cells and Lung Cancer Cells.
Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progression.
Set7/9 controls proliferation and genotoxic drug resistance of NSCLC cells.
SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.
SET7/9 promotes multiple malignant processes in breast cancer development via RUNX2 activation and is negatively regulated by TRIM21.
SET7/9 regulates cancer cell proliferation by influencing ?-catenin stability.
Small-Molecule Inhibitors of the Protein Methyltransferase SET7/9 Identified in a High-Throughput Screen.
Structural basis for the methylation site specificity of SET7/9.
Obesity
Set7/9, a methyltransferase, regulates the thermogenic program during brown adipocyte differentiation through the modulation of p53 acetylation.
Peritoneal Fibrosis
Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis.
Prostatic Neoplasms
Histone H3K4 Methyltransferases as Targets for Drug-Resistant Cancers.
Renal Insufficiency, Chronic
Histone Lysine Methylation in TGF-?1 Mediated p21 Gene Expression in Rat Mesangial Cells.
Stomach Neoplasms
Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progression.
Triple Negative Breast Neoplasms
Histone H3K4 Methyltransferases as Targets for Drug-Resistant Cancers.
Ureteral Obstruction
Inhibition of SET Domain-Containing Lysine Methyltransferase 7/9 Ameliorates Renal Fibrosis.